cdmo.directory
← Compare landing

Cellipont Bioservices vs Cell and Gene Therapy Catapult

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cellipont-bioservices/ct

CategoryCellipont BioservicesCell and Gene Therapy Catapult
Listed sitecdmocdmo
SummaryCell therapy CDMO offering process development, analytical services, and cGMP manufacturing for CAR-T, TCR-T, allogeneic, autologous, and iPSC-derived therapies from preclinical through commercial stages.UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • Cell-Line Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Upstream Processing
  • Downstream Processing
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
Modalities
  • Cell Therapy
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Oncology
  • Oncology
  • Immunology
  • Neurology
  • Rare Disease
Locations
  • Headquarters & Manufacturing Facility, The Woodlands, Texas, United States
  • Headquarters, Stevenage, Hertfordshire, United Kingdom
  • London, London, England, United Kingdom
  • Braintree, Braintree, Essex, United Kingdom
  • Edinburgh, Edinburgh, Scotland, United Kingdom
  • Headquarters, United Kingdom
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.